Roshini Prakash

Roshini Prakash is a highly experienced professional in the fields of oncology and medical science, currently serving as Director of Oncology at Jazz Pharmaceuticals since May 2020, where responsibilities include target portfolio planning and managing clinical trials for advanced refractory solid tumors. Prior roles include Medical Science Liaison positions at Takeda and Amgen, where Roshini contributed to product launches and medical strategies. Roshini's academic background includes a Ph.D. in Clinical and Experimental Therapeutics from The University of Georgia and notable postdoctoral research at the David Geffen School of Medicine at UCLA, focusing on stroke repair and cancer mechanisms. With a strong foundation in therapeutic research, evidenced by multiple publications, Roshini also has experience in communication and leadership through involvement in Toastmasters International and Gordon Research Conferences.